Head and Neck Neoplasms  >>  oxaliplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT01824459: S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients

Completed
3
576
RoW
S-1, Oxaliplatin, Cisplatin
Sun Yat-sen University, Taiho Pharmaceutical Co., Ltd.
Gastric Cancer
12/18
12/18

Download Options